136 related articles for article (PubMed ID: 38319415)
21. Neutrophils correlate with hypoxia microenvironment and promote progression of non-small-cell lung cancer.
Zhang C; Tang B; Hu J; Fang X; Bian H; Han J; Hou C; Sun F
Bioengineered; 2021 Dec; 12(1):8872-8884. PubMed ID: 34637697
[TBL] [Abstract][Full Text] [Related]
22. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer.
Wu F; Fan J; He Y; Xiong A; Yu J; Li Y; Zhang Y; Zhao W; Zhou F; Li W; Zhang J; Zhang X; Qiao M; Gao G; Chen S; Chen X; Li X; Hou L; Wu C; Su C; Ren S; Odenthal M; Buettner R; Fang N; Zhou C
Nat Commun; 2021 May; 12(1):2540. PubMed ID: 33953163
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of the neutrophil-to-lymphocyte ratio and primary tumor location in epidermal growth factor receptor-mutated metastatic non-small cell lung cancer.
Xie X; Li X; Tang W; Chen J; Xie P; Li M
J Cancer Res Ther; 2021 Dec; 17(7):1618-1625. PubMed ID: 35381730
[TBL] [Abstract][Full Text] [Related]
24. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.
Tsai CM; Chang KT; Perng RP; Mitsudomi T; Chen MH; Kadoyama C; Gazdar AF
J Natl Cancer Inst; 1993 Jun; 85(11):897-901. PubMed ID: 8098377
[TBL] [Abstract][Full Text] [Related]
25. Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles.
Liu T; Wang J; Li T; Cui P; Hou B; Zhuang C; Wei G; Zhang S; Li H; Hu Y
BMC Cancer; 2021 Aug; 21(1):939. PubMed ID: 34416874
[TBL] [Abstract][Full Text] [Related]
26. The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.
Öjlert ÅK; Halvorsen AR; Nebdal D; Lund-Iversen M; Solberg S; Brustugun OT; Lingjaerde OC; Helland Å
Mol Oncol; 2019 May; 13(5):1166-1179. PubMed ID: 30854794
[TBL] [Abstract][Full Text] [Related]
27. Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.
Hirsch FR; Helfrich B; Franklin WA; Varella-Garcia M; Chan DC; Bunn PA
Clin Breast Cancer; 2002 May; 3 Suppl 1():12-6. PubMed ID: 12057039
[TBL] [Abstract][Full Text] [Related]
28. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer.
Shi J; Li J; Wang H; Li X; Wang Q; Zhao C; Cheng L; Han R; Chen P; Guo H; Tang Z; Zhou C; Zhang Z; Wu F
Lung Cancer (Auckl); 2023; 14():85-99. PubMed ID: 38025400
[TBL] [Abstract][Full Text] [Related]
30. Immune Cell Composition in Human Non-small Cell Lung Cancer.
Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Front Immunol; 2018; 9():3101. PubMed ID: 30774636
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang N; Jiang J; Tang S; Sun G
Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
[TBL] [Abstract][Full Text] [Related]
32. The Effect of Lung Resection for NSCLC on Circulating Immune Cells: A Pilot Study.
Phillips JD; Fay KA; Bergeron AJ; Zhang P; Mielcarz DW; Calkins AM; Searles TG; Christensen BC; Finley DJ; Turk MJ; Channon JY
Curr Oncol; 2023 May; 30(5):5116-5134. PubMed ID: 37232845
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis.
Yin Y; Wang J; Wang X; Gu L; Pei H; Kuai S; Zhang Y; Shang Z
Clinics (Sao Paulo); 2015 Jul; 70(7):524-30. PubMed ID: 26222823
[TBL] [Abstract][Full Text] [Related]
34. IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer.
Rotondo R; Barisione G; Mastracci L; Grossi F; Orengo AM; Costa R; Truini M; Fabbi M; Ferrini S; Barbieri O
Int J Cancer; 2009 Aug; 125(4):887-93. PubMed ID: 19431148
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
Brabender J; Danenberg KD; Metzger R; Schneider PM; Park J; Salonga D; Hölscher AH; Danenberg PV
Clin Cancer Res; 2001 Jul; 7(7):1850-5. PubMed ID: 11448895
[TBL] [Abstract][Full Text] [Related]
36. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer.
Zhao T; Liu S; Hanna NH; Jalal S; Ding X; Wan J; Yan C; Du H
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36914206
[TBL] [Abstract][Full Text] [Related]
37. Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer.
Beeh KM; Beier J; Ernst M; Kornmann O; Buhl R
Respiration; 2003; 70(2):166-71. PubMed ID: 12740514
[TBL] [Abstract][Full Text] [Related]
38. The circulating urokinase plasminogen activator (uPA) and its soluble receptor (suPAR) are not up-regulated by the circulating P105 fraction of the HER-2/neu proto-oncogene: in vivo evidence from patients with advanced non-small cell lung cancer (NSCLC).
Jumper C; Cobos E; Lox C
Anticancer Res; 2002; 22(4):2073-6. PubMed ID: 12174885
[TBL] [Abstract][Full Text] [Related]
39. Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19.
de Oliveira Formiga R; Amaral FC; Souza CF; Mendes DAGB; Wanderley CWS; Lorenzini CB; Santos AA; Antônia J; Faria LF; Natale CC; Paula NM; Silva PCS; Fonseca FR; Aires L; Heck N; Starick MR; Queiroz-Junior CM; Santos FRS; de Souza FRO; Costa VV; Barroso SPC; Morrot A; Van Weyenbergh J; Sordi R; Alisson-Silva F; Cunha FQ; Rocha EL; Chollet-Martin S; Hurtado-Nedelec MM; Martin C; Burgel PR; Mansur DS; Maurici R; Macauley MS; Báfica A; Witko-Sarsat V; Spiller F
Br J Pharmacol; 2023 Jun; 180(11):1460-1481. PubMed ID: 36526272
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer.
Ohashi K; Nishito Y; Fukuda H; Sadahiro R; Yoshida Y; Watanabe SI; Motoi N; Sonobe Y; Mizuno H; Tsunoda H; Tatsumi K; Suzuki T; Ochiai A; Aoki K
Sci Rep; 2024 Jan; 14(1):429. PubMed ID: 38172491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
